APOPPS is AN IPOP Robert N. Brown, Sr., CPO, FAAOP APOPPS: Inventor, Manufacturer & Distributor Robert N. Brown, Sr., CPO, FAAOP APOPPS: Inventor, Manufacturer.

Slides:

Advertisements

Similar presentations

The APOPPS™ & APOPPS-TF™ by FLO-TECH® O&P Systems, Inc.

Advertisements

Robert N. Brown, Sr., CPO, FAAOP

Where Art Thou Diabetic Limb Salvage Data?: A Literature Review and Subsequent Challenge to the Diabetic Limb Salvage Community Christine K. Nolan, DPM.

A Comparison Of Endovascular And Open Approaches To The Treatment Of Aneurysms Of The Descending Aorta: Outcomes Differ By Severity Of Co-morbid Diseases.

Matthew S. Slater, MD, Brian S. Diggs, PhD Frederick A. Tibayan, MD Steven G Guyton, MD, MPH Howard K. Song, MD, PhD The Department of Surgery, and the.

Improved performance of the Diabetes LDL control measure Dr Stuart V Demirs MD.

LOCKTON DUNNING BENEFITS UNIVERSITY OF ALASKA 2ND QTR FY13 UTILIZATION REVIEW 7/1/2012 TO 12/31/2012.

ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.

Discharge Documentation Audit Jure Baloh, Julie Brandt, PhD, Douglas Wakefield, PhD, Becky Morton, RHIA, Kay Davis, PhD, RN, Robert Hodge, MD Center for.

Lessons Learned from the Society of Thoracic Surgeons (STS) Congenital Database September 25, 2015 Robert J. Dabal, MD Associate Professor of Surgery.

Comparing State and National Injury Statistics Examples from Colorado Holly Hedegaard, MD, MSPH EMS and Trauma Data Program Emergency Medical and Trauma.

Duramorph –A Cost Analysis Scott Frankfather, M.D. PGY IV Robert Casanova, M.D. Texas Tech Physicians Department of Obstetrics and Gynecology March 6,

Comments to „A“: „The health care system“ Arie Hasman & Achim Hochlehnert Health Care in the Information Society - on the Prognosis for the Year 2013 Workshop.

EXPERTISEPARTNERSHIP VALUE August 20, TH QUARTER FY11 UTILIZATION REVIEW – 7/1/2010 TO 6/30/2011 TRENDSANALYSISSTATISTICSPLANNINGTOOLS.

Department of Cardiothoracic and Vascular Surgery 1 School of Public Health 2 The University of Texas Medical School at Houston Memorial Hermann Heart.

DHHS COE Meeting Agenda Contract Compliance Reporting Contract Update Questions and Answers.

Disparity between reality and the perception of case volume needed to train competent general surgeons Fariha Sheikh MD 1, Richard J. Gray MD 1, John Ferrara.

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers David L. Steed, MD, the.

To compare demographic and clinical characteristics of those with and without diabetes that undergo a lower extremity amputation in Glasgow, UK Fiona.

New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery Stephen.

Min-Woong Sohn, PhD, Judith L. Meadows, MD, Elissa H

Bipolar Hemiarthroplasty – Does It Make Sense in AVNF?

FEATURED TEAM: General and Plastic Surgery, Fontana Medical Center Wait times irritating members? Here's a solution WHAT THEY DO: To keep patients informed.

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia Louis L. Nguyen,

Defining successful mobility after lower extremity amputation for complications of peripheral vascular disease and diabetes Daniel C. Norvell, PhD, Aaron.

Racial differences in primary and repeat lower extremity amputation: Results from a multihospital study Joe Feinglass, PhD, Cheryl Rucker-Whitaker, MD,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Woman With Leg Rash Annals of Emergency Medicine

Joshua B. Goldberg, MD, Philip P. Goodney, MD, MS, Jack L

Impact of amputation level and comorbidities on functional status of nursing home residents after lower extremity amputation Todd R. Vogel, MD, MPH,

Lower Limb Amputations in Patients With Diabetes and Peripheral Artery Disease: A Time-Series Analysis of Trends ( ) Mohamad A. Hussain, MD,

Comparison of risk factors for length of stay and readmission following lower extremity bypass surgery Scott M. Damrauer, MD, Ann C. Gaffey, MD, Ann.

The development and validation of the AMPREDICT model for predicting mobility outcome after dysvascular lower extremity amputation Joseph M. Czerniecki,

Definition of venous reflux in lower-extremity veins

“Better” (sometimes) in vascular disease management

Presidential address: The American Association for Vascular Surgery: A tradition of imagination, innovation, and change William H. Pearce, MD Journal.

Risk factors and indications for readmission after lower extremity amputation in the American College of Surgeons National Surgical Quality Improvement.

The best of times, the worst of times…

The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia Mohammad.

John Lockwood Ochsner: Celebration of life

P. Ponraj, MS, FRCS, Paolo Masiello, MD, Alun Rees, FRCS

David T. Vroman, MD Assistant Professor of Ophthalmology

Zachary B. Fang, BS, Frances Y. Hu, BA, Shipra Arya, MD, Theresa W

Incidence of ipsilateral postoperative deep venous thrombosis in the amputated lower extremity of patients with peripheral obstructive arterial disease

SS14. Outcomes Comparison of Chest Wall Arteriovenous Grafts and Lower Extremity Arteriovenous Grafts in Patients With Long-Standing Renal Failure Jie.

Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia Vincent J. Santo, MD, Phong T. Dargon,

Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative Jeffrey J. Siracuse, MD, Matthew.

Todd R. Vogel, MD, MPH, Gregory F. Petroski, PhD, Robin L. Kruse, PhD

Maryland HCW Influenza Vaccination Survey Highlights

Peter Neglén, MD, PhD, Seshadri Raju, MD Journal of Vascular Surgery

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Comparison of contrast arteriography to arterial mapping with color-flow duplex imaging in the lower extremities David V. Cossman, MD, Jean E. Ellison,

Sac behavior after aneurysm treatment with the Gore Excluder low-permeability aortic endoprosthesis: 12-month comparison to the original Excluder device

Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations Dirk Th. Ubbink, MD,

Philip P. Goodney, MD, MS, Adam W. Beck, MD, Jan Nagle, MS, RPh, H

Kara H. V. Kvilekval, MD, Jonathan P. Yunis, MD, Robert A

Jessica P. Simons, MD, MPH, Andres Schanzer, MD, Brian W

The Society for Vascular Surgery's objective performance goals for lower extremity revascularization are not generalizable to many open surgical bypass.

Cassius Iyad Ochoa Chaar, MD, Michel S. Makaroun, MD, Luke K

Prevention of radiation injury from medical imaging

Above-knee amputation in patients with prior hip surgery: a caveat

The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus

Todd R. Vogel, Viktor Y. Dombrovskiy, MD PhD MPH, Paul B

Homologous veins as an arterial substitute: Long-term results

Correction Journal of Vascular Surgery

Randall W. Franz, MD, FACS, RVT, Kaushal J

J. David Neel, MD, Robin L. Kruse, PhD, Viktor Y

Lower extremity lymphedema caused by acquired immune deficiency syndrome – related Kaposi's sarcoma: Case report and review of the literature Peter J.

Dr. Dr. Mack Thomas is on staff in Ochsner's Department of Anesthesiology. He served as the Director of the Acute and Chronic Pain Program at the New Orleans.

Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease James J. Schuler,

Presentation transcript:

APOPPS is AN IPOP Robert N. Brown, Sr., CPO, FAAOP APOPPS: Inventor, Manufacturer & Distributor Robert N. Brown, Sr., CPO, FAAOP APOPPS: Inventor, Manufacturer & Distributor

SUMMARY The Rehabilitation Value & Cost Effectiveness Of IPOP For Major Lower Extremity Amputation n Malone, Pipinich, Leal, Hayden & Simpson n Department Of Surgery, Department Of Vascular Surgery n Maricopa Medical Center n Phoenix, Arizona 85010

IPOP Success Rates n Unchanged in the last 50 years at 60% –Despite improvements in the field n 95% success rate at Maricopa Medical Center –Learn more using recommended reading in your Program Books

Results at Maricopa Medical Center n Time to Preparatory Prosthesis –32 – 23 days if 3 patients are excluded, due to falls n Extremely rare in an APOPPS, FLO-TECH-TOR n Time to Definitive Prosthesis –Average 186 days = 6 months –3 to 11 months = 90 to 336

APOPPS Comparison –24 days to APOPPS Prep System or Preparatory prosthesis –66 days to definitive prosthesis n Data from J.Kaufman, MD, K Galang, MD –Ochsner Medical Center, New Orleans, Louisiana n K. Bordelone, CP –Hanger P&O, New Orleans, Louisiana

Cost Comparisons from Maricopa Medical Center Study Reference Cost Length of Stay Reference Cost Length of Stay –Non IPOP $47,589 unknown –IPOP n Uncorrected $42, days –Includes 4 patients whose other medical complications resulted in stays 3 to 8 times above the average stay –IPOP n Corrected $28, days –4 patients excluded from the data